Section 4804. Access to specialty care  


Latest version.
  • (a) If an insurer offering a managed
      care  product determines that it does not have a health care provider in
      the in-network benefits portion of its network with appropriate training
      and experience to meet the particular health care needs of  an  insured,
      the  insurer  shall make a referral to an appropriate provider, pursuant
      to a treatment plan approved by the insurer  in  consultation  with  the
      primary care provider, the non-participating provider and the insured or
      the insured's designee, at no additional cost to the insured beyond what
      the  insured  would  otherwise  pay  for  services  received  within the
      network.
        (b) An insurer offering a managed care product shall have a  procedure
      by  which  an  insured  enrolled  in such managed care product who needs
      ongoing care from a specialist may receive a standing referral  to  such
      specialist. If the insurer, or the primary care provider in consultation
      with  the  insurer  and  the specialist, determines that such a standing
      referral is appropriate, the insurer shall make such  a  referral  to  a
      specialist.  In  no  event  shall  an  insurer  be required to permit an
      insured to elect to have a non-participating specialist, except pursuant
      to the provisions of subsection (a) of this section. Such referral shall
      be pursuant to a treatment plan approved by the insurer in  consultation
      with  the  primary care provider, the specialist, and the insured or the
      insured's designee. Such treatment plan may limit the number  of  visits
      or  the  period  during which such visits are authorized and may require
      the specialist to provide the primary care provider with regular updates
      on the specialty  care  provided,  as  well  as  all  necessary  medical
      information.
        (c)  An  insurer  shall  have  a procedure by which a new insured upon
      enrollment in a managed care product, or an insured in  a  managed  care
      product upon diagnosis, with (1) a life-threatening condition or disease
      or  (2)  a  degenerative  and  disabling condition or disease, either of
      which requires specialized medical care over a prolonged period of time,
      may receive a referral to a specialist with expertise  in  treating  the
      life-threatening  or degenerative and disabling disease or condition who
      shall be responsible for and capable of providing and  coordinating  the
      insured's  primary  and  specialty care. If the insurer, or primary care
      provider in consultation with the insurer and the  specialist,  if  any,
      determines   that   the  insured's  care  would  most  appropriately  be
      coordinated by such a specialist, the insurer shall refer the insured to
      such specialist. In no event shall an insurer be required to  permit  an
      insured to elect to have a non-participating specialist, except pursuant
      to the provisions of subsection (a) of this section. Such referral shall
      be pursuant to a treatment plan approved by the insurer, in consultation
      with  the  primary care provider if appropriate, the specialist, and the
      insured or the insured's designee. Such specialist shall be permitted to
      treat the insured without a referral from  the  insured's  primary  care
      provider  and  may authorize such referrals, procedures, tests and other
      medical services as the insured's primary care provider would  otherwise
      be  permitted  to  provide  or  authorize,  subject  to the terms of the
      treatment plan. If an insurer refers an insured to  a  non-participating
      provider,  services  provided  pursuant  to  the approved treatment plan
      shall be provided at no additional cost to the insured beyond  what  the
      insured would otherwise pay for services received within the network.
        (d)  An insurer offering a managed care product shall have a procedure
      by which an insured enrolled in such managed care  product  with  (1)  a
      life-threatening   condition  or  disease  or  (2)  a  degenerative  and
      disabling condition or disease, either  of  which  requires  specialized
      medical  care over a prolonged period of time, may receive a referral to
      a specialty care center with expertise in treating the  life-threatening
    
      or  degenerative  and disabling disease or condition. If the insurer, or
      the primary care provider  or  the  specialist  designated  pursuant  to
      subsection  (c)  of  this  section,  in  consultation  with the insurer,
      determines  that the insured's care would most appropriately be provided
      by such a specialty care center, the insurer shall refer the insured  to
      such  center.    In  no  event shall an insurer be required to permit an
      insured to elect to have a  non-participating  speciality  care  center,
      unless the insurer does not have an appropriate specialty care center to
      treat  the  insured's  disease  or  condition  within  its network. Such
      referral shall  be  pursuant  to  a  treatment  plan  developed  by  the
      specialty  care center and approved by the insurer, in consultation with
      the primary care provider, if any, or a specialist  designated  pursuant
      to  subsection  (c)  of  this  section, and the insured or the insured's
      designee. If an insurer refers an insured to  a  specialty  care  center
      that  does  not  participate  in  the  insurer's  managed  care provider
      network, services provided pursuant to the approved treatment plan shall
      be provided at no additional cost to the insured beyond what the insured
      would otherwise pay  for  services  received  within  the  network.  For
      purposes  of  this  subsection,  a specialty care center shall mean only
      such centers as are accredited or designated by an agency of  the  state
      or  federal government or by a voluntary national health organization as
      having special expertise in treating  the  life-threatening  disease  or
      condition  or  degenerative and disabling disease or condition for which
      it is accredited or designated.
        (e) (1) If an insured's health  care  provider  leaves  the  insurer's
      in-network  benefits  portion  of its network of providers for a managed
      care product for reasons other than those for which the  provider  would
      not  be  eligible  to  receive  a  hearing  pursuant to paragraph one of
      subsection (b) of section forty-eight hundred three of this chapter, the
      insurer shall permit the  insured  to  continue  an  ongoing  course  of
      treatment  with  the  insured's  current  health  care provider during a
      transitional period of (i) up to ninety days from the date of notice  to
      the insured of the provider's disaffiliation from the insurer's network;
      or  (ii) if the insured has entered the second trimester of pregnancy at
      the time of the provider's disaffiliation,  for  a  transitional  period
      that  includes the provision of post-partum care directly related to the
      delivery.
        (2)  Notwithstanding  the  provisions  of  paragraph   one   of   this
      subsection,  such  care  shall  be  authorized by the insurer during the
      transitional period only if the  health  care  provider  agrees  (i)  to
      continue   to  accept  reimbursement  from  the  insurer  at  the  rates
      applicable prior to the start of the transitional period as  payment  in
      full; (ii) to adhere to the insurer's quality assurance requirements and
      to  provide to the insurer necessary medical information related to such
      care; and (iii) to  otherwise  adhere  to  the  insurer's  policies  and
      procedures  including, but not limited to procedures regarding referrals
      and obtaining pre-authorization and a treatment  plan  approved  by  the
      insurer.
        (f) If a new insured whose health care provider is not a member of the
      insurer's in-network benefits portion of the provider network enrolls in
      the  managed  care  product,  the  insurer  shall  permit the insured to
      continue an ongoing course  of  treatment  with  the  insured's  current
      health  care  provider  during a transitional period of up to sixty days
      from the effective  date  of  enrollment,  if  (1)  the  insured  has  a
      life-threatening  disease  or  condition or a degenerative and disabling
      disease or condition or (2) the insured has entered the second trimester
      of pregnancy at the time of enrollment, in which case  the  transitional
      period  shall include the provision of post-partum care directly related
    
      to the delivery.  If an insured elects to continue to receive care  from
      such health care provider pursuant to this paragraph, such care shall be
      authorized by the insurer for the transitional period only if the health
      care  provider  agrees  (A)  to accept reimbursement from the insurer at
      rates established by the insurer as payment in full, which  rates  shall
      be  no  more  than  the  level  of  reimbursement  applicable to similar
      providers within  the  in-network  benefits  portion  of  the  insurer's
      network  for  such  services;  (B)  to  adhere  to the insurer's quality
      assurance requirements and agrees to provide to  the  insurer  necessary
      medical information related to such care; and (C) to otherwise adhere to
      the  insurer's  policies  and  procedures  including, but not limited to
      procedures regarding referrals and  obtaining  pre-authorization  and  a
      treatment  plan  approved  by  the  insurer.    In  no  event shall this
      subsection be construed to require an insurer to  provide  coverage  for
      benefits  not  otherwise  covered  or to diminish or impair pre-existing
      condition limitations contained within the insured's contract.